Hippo pathway in cancer cells induces NCAM1+αSMA+ fibroblasts to modulate tumor microenvironmentChanida Thinyakul, Toshiro Moroishi|Communications Biology|2024Cited by 11
Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapyMayumi Niimura, Toshiro Moroishi|Communications Medicine|2025Cited by 2
Peptide Modulation Overrides Glycan Synergy in Gold Nanoparticle‐Based Vaccines for Cancer ImmunotherapyNarumi Harada, Toshiro Moroishi|Cancer Medicine|2025Cited by 1
Hippo pathway in cancer cells modulates tumor microenvironment by inducing immunosuppressive NCAM1+αSMA+ fibroblastsToshiro Moroishi, Chanitra Thuwajit|Research Square|2024Cited by 0